13.50
+0.19
+(1.43%)
At close: January 30 at 4:00:00 PM EST
13.01
-0.54
(-3.99%)
Pre-Market: 5:13:40 AM EST
Key Executives
Key Executives Information Not Available
Palvella Therapeutics, Inc.
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Palvella Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 27, 2025 at 8:00 PM UTC - March 31, 2025 at 8:00 PM UTC
Palvella Therapeutics, Inc. Earnings Date
Recent Events
Related Tickers
OKUR OnKure Therapeutics, Inc.
5.83
+10.42%
MLYS Mineralys Therapeutics, Inc.
10.27
-0.87%
ZBIO Zenas BioPharma, Inc.
7.62
+4.53%
MTVA MetaVia Inc.
1.8800
-0.53%
UR9.SG Clinuvel Pharmaceuticals Ltd
7.16
-0.49%
UTH.MU United Therapeutics Corp
343.80
-3.70%
ZLDAF Zelira Therapeutics Limited
0.3334
0.00%
FENC Fennec Pharmaceuticals Inc.
6.55
+1.24%
SEELQ Seelos Therapeutics, Inc.
0.0030
+2,900.00%
APGE Apogee Therapeutics, Inc.
42.50
+5.41%